Performance analysis of Eledon Pharmaceuticals (ELDN)
Annual Return
Over the past 3 years, ELDN has had an average annual return of +21.67%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, ELDN has had an average annual return of -17.84%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, ELDN has had an average annual return of -43.91%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Sep 17, 2014, ELDN has had an average annual return of -45.04%, underperforming the benchmark SPY, which returned +13.88% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +125% | -63.64% | +120% | -16.67% | -45.45% | -72.50% | +48.15% | -64.00% | -60.53% | -53.88% | -88.77% | -40.84% |
| 2014 | |||||||||||
| -37.96% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +50% | +16.67% | +14.29% | +12.50% | +11.11% | -10.00% | +125% | ||||||
| 2025 | +9.09% | -8.33% | -18.18% | -11.11% | +0% | -12.50% | +14.29% | -12.50% | +0% | +57.14% | -63.64% | +0% | -63.64% |
| 2024 | +0% | +0% | +0% | +20% | +16.67% | +0% | +14.29% | -12.50% | -14.29% | +100% | +0% | -8.33% | +120% |
| 2023 | +50% | -33.33% | +0% | -16.67% | +0% | -20.00% | +0% | +0% | +0% | +0% | -25.00% | +66.67% | -16.67% |
| 2022 | +0% | -18.18% | +11.11% | -20.00% | +0% | -25.00% | +33.33% | +25% | -30.00% | -14.29% | +0% | +0% | -45.45% |
| 2021 | -2.50% | +7.69% | -33.33% | -7.14% | -3.85% | -16.00% | -19.05% | +29.41% | -27.27% | -18.75% | +0% | -15.38% | -72.50% |
| 2020 | +3.70% | -7.14% | -30.77% | +77.78% | +84.37% | -64.41% | +0% | -4.76% | +120% | +54.55% | -7.35% | -36.51% | +48.15% |
| 2019 | +168% | +12.44% | -16.81% | -34.04% | -35.48% | -41.25% | -17.02% | -12.82% | -14.71% | -0% | +6.90% | -12.90% | -64.00% |
| 2018 | -10.53% | +1.18% | +37.21% | -12.71% | +85.92% | -14.62% | +4.89% | -35.28% | -1.80% | -27.98% | +3.18% | -53.70% | -60.53% |
| 2017 | -3.88% | -12.88% | +2.03% | -26.99% | -7.00% | +14.64% | -31.39% | -1.60% | +31.89% | -27.46% | +9.60% | -2.06% | -53.88% |
Drawdown analysis of Eledon Pharmaceuticals (ELDN)
The maximum drawdown for the ELDN was -99.97%, occurring on Jun 26, 2023. This drawdown has not yet recovered.
The current ELDN drawdown is -99.91%.
Since Sep 17, 2014 ELDN has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.97% | Sep 17, 2014 | 2207 | Jun 26, 2023 | Ongoing | Ongoing | Ongoing |